Genpact (G) Cash & Equivalents (2009 - 2026)

Genpact's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $578.1 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 2.93% year-over-year to $578.1 million; the TTM figure through Mar 2026 stood at $578.1 million (up 2.93% YoY), while the FY2025 annual figure was $853.8 million, up 31.71% from the prior year.
• Cash & Equivalents was $578.1 million for Q1 2026 at Genpact, down from $853.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.0 billion in Q3 2024 to a low of $460.4 million in Q2 2022.
• Historically, Cash & Equivalents has averaged $653.9 million across 5 years, with a median of $583.7 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents plunged 43.77% in 2022, then soared 89.03% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $646.8 million in 2022, then retreated by 9.76% to $583.7 million in 2023, then grew by 11.06% to $648.2 million in 2024, then jumped by 31.71% to $853.8 million in 2025, then slumped by 32.3% to $578.1 million in 2026.
• The last three Cash & Equivalents figures came in at $578.1 million (Q1 2026), $853.8 million (Q4 2025), and $740.8 million (Q3 2025), per Business Quant data.